Protective effects of exogenous glutathione and related thiol compounds against drug-induced liver injury

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 3, 2011, Pages 366-370

  Masubuchi, Yasuhiro ^a   Nakayama, Junpei ^a   Sadakata, Yuka ^a  

^a CHIBA INSTITUTE OF SCIENCE   (Japan)

Author keywords

Acetaminophen; Furosemide; Glutathione; Hepatotoxicity; Interleukin 6; N acetylcysteine

Indexed keywords

ACETYLCYSTEINE; ALANINE AMINOTRANSFERASE; CYSTEINE; FUROSEMIDE; GLUTATHIONE; GLUTATHIONE ETHYL ESTER; INTERLEUKIN 6; PARACETAMOL; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; LIVER INJURY; LIVER LEVEL; LIVER PROTECTION; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ACETAMINOPHEN; ACETYLCYSTEINE; ANIMALS; ANTI-INFLAMMATORY AGENTS; DRUG-INDUCED LIVER INJURY; FEMALE; FUROSEMIDE; GLUTATHIONE; INTERLEUKIN-6; LIVER; MALE; MICE; MICE, INBRED STRAINS;

EID: 79952348959     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.366     Document Type: Article

References (23)

1. Mitchell J. R., Jollow D. J., Potter W. Z., Davis D. C., Gillette J. R., Brodie B. B., J. Pharmacol. Exp. Ther., 187, 185-194 (1973).
2. Jollow D. J., Mitchell J. R., Potter W. Z., Davis D. C., Gillette J. R., Brodie B. B., J. Pharmacol. Exp. Ther., 187, 195-202 (1973).
3. Dahlin D. C., Miwa G. T., Lu A. Y., Nelson S. D., Proc. Natl. Acad. Sci. U.S.A., 81, 1327-1331 (1984).
4. Prescott L. F., Park J., Ballantyne A., Adriaenssens P., Proudfoot A. T., Lancet, 2, 432-434 (1977).
5. Corcoran G. B., Wong B. K., J. Pharmacol. Exp. Ther., 238, 54-61 (1986).
6. Harrison P. M., Keays R., Bray G. P., Alexander G. J., Williams R., Lancet, 335, 1572-1573 (1990).
7. James L. P., McCullough S. S., Lamps L. W., Hinson J. A., Toxicol. Sci., 75, 458-467 (2003).
8. Salminen W. F. Jr., Voellmy R., Roberts S. M., J. Pharmacol. Exp. Ther., 286, 519-524 (1998).
9. Dambach D. M., Durham S. K., Laskin J. D., Laskin D. L., Toxicol. Appl. Pharmacol., 211, 157-165 (2006).
10. Puri R. N., Meister A., Proc. Natl. Acad. Sci. U.S.A., 80, 5258-5260 (1983).
11. Knight T. R., Ho Y. S., Farhood A., Jaeschke H., J. Pharmacol. Exp. Ther., 303, 468-475 (2002).
12. Anderson M. E., Methods Enzymol., 113, 548-555 (1985).
13. Masubuchi Y., Sugiyama S., Horie T., Chem. Biol. Interact., 179, 273-279 (2009).
14. Blazka M. E., Wilmer J. L., Holladay S. D., Wilson R. E., Luster M. I., Toxicol. Appl. Pharmacol., 133, 43-52 (1995).
15. Ishida Y., Kondo T., Tsuneyama K., Lu P., Takayasu T., Mukaida N., J. Leukoc. Biol., 75, 59-67 (2004).
16. Masubuchi Y., Bourdi M., Reilly T. P., Graf M. L., George J. W., Pohl L. R., Biochem. Biophys. Res. Commun., 304, 207-212 (2003).
17. Mitchell J. R., Nelson W. L., Potter W. Z., Sasame H. A., Jollow D. J., J. Pharmacol. Exp. Ther., 199, 41-52 (1976).
18. Carlson G., J. Toxicol. Environ. Health A, 67, 905-909 (2004).
19. Martignoni M., Groothuis G., de Kanter R., Drug Metab. Dispos., 34, 1047-1054 (2006).
20. Wong S. G., Card J. W., Racz W. J., Toxicol. Lett., 116, 171-181 (2000).
21. Randle L. E., Goldring C. E., Benson C. A., Metcalfe P. N., Kitteringham N. R., Park B. K., Williams D. P., Toxicology, 243, 249-260 (2008).
22. Bessems J. G., Vermeulen N. P., Crit. Rev. Toxicol., 31, 55-138 (2001).
23. Kao L. W., Kirk M. A., Furbee R. B., Mehta N. H., Skinner J. R., Brizendine E. J., Ann. Emerg. Med., 42, 741-750 (2003).